StonvexLoading…
StonvexStonvexStonvexCore line items from AHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $69.80M | $609.77M | $2.09B | $1.53B | $998.46M |
Operating Income | Not available | $125.50M | $415.16M | $303.58M | $197.76M |
Net Income | Not available | $23.71M | $69.81M | $59.03M | $3.10M |
EPS (Diluted) | $0.02 | $0.13 | $0.42 | $0.36 | $0.02 |
Total Assets | Not available | $5.60B | $5.43B | $4.77B | $4.51B |
Total Liabilities | Not available | $2.08B | $2.07B | $2.05B | $2.04B |
Cash & Equivalents | Not available | $119.38M | $114.84M | $147.36M | $133.49M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 189.94M | 185.91M | 162.91M | 159.32M |